Product Introduction
Bioactivity


英文名: Laniquidar TFA

描述: Laniquidar TFA (R101933) 是一种新型口服非竞争性P-糖蛋白(P-gp)抑制剂，IC50 值为 0.51 μM。Laniquidar的生物利用度有限，可用于调节多药耐药性转运体。Laniquidar可用于研究急性髓性白血病(AML)和骨髓增生异常综合征(MDS)。

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

关键字: Laniquidar TFA | R 101933 | R-101933

相关产品: Tenacigenin B | Bacoside A3 | Cinobufotalin | YS-370 | Voacamine | Furanodiene | Encequidar mesylate | Phellamurin | PGP-4008 | Tepotinib hydrochloride(1 : x)

相关库: Drug Repurposing Compound Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Anti-Cancer Active Compound Library